{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:24:34Z","timestamp":1791498274062,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jns.2019.116638","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T11:52:59Z","timestamp":1576497179000},"page":"116638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Differential leukocyte count is associated with clinical phenotype in Parkinson's disease"],"prefix":"10.1016","volume":"409","author":[{"given":"Tadashi","family":"Umehara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisayoshi","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuo","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Matsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetomo","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2019.116638_bb0005","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/334345a0","article-title":"Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson\u2019s disease","volume":"334","author":"Hirsch","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jns.2019.116638_bb0010","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/jnnp-2015-311890","article-title":"The prediagnostic phase of Parkinson\u2019s disease","volume":"87","author":"Noyce","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.116638_bb0015","first-page":"508","article-title":"Neutrophil-derived cytokines: facts beyond expression","volume":"5","author":"Tecchio","year":"2014","journal-title":"Front. Imuunol."},{"key":"10.1016\/j.jns.2019.116638_bb0020","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2019.116638_bb0025","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1196\/annals.1332.007","article-title":"Inflammation and the degenerative diseases of aging","volume":"1035","author":"McGeer","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jns.2019.116638_bb0030","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1600-0404.1998.tb01736.x","article-title":"Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson\u2019s disease","volume":"98","author":"M\u00fcller","year":"1998","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2019.116638_bb0035","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/mds.26563","article-title":"ICICLE-PD study group, serum immune markers and disease progression in an incident Parkinson\u2019s disease cohort (ICICLE-PD)","volume":"31","author":"Williams-Gray","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2019.116638_bb0040","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease. A clinic-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.116638_bb0045","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00702-006-0518-2","article-title":"Striatal FP-CIT uptake differs in the subtypes of early Parkinson\u2019s disease","volume":"114","author":"Spiegel","year":"2007","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jns.2019.116638_bb0050","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"WHO Expert Consultation","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2019.116638_bb0055","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00415-009-5447-1","article-title":"Olfactory dysfunction and cardiovascular dysautonomia in Parkinson\u2019s disease","volume":"257","author":"Oka","year":"2010","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2019.116638_bb0060","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2500\/ajra.2011.25.3658","article-title":"Applicability of the cross-culturally modified University of Pennsylvania Smell Identification Test in a Japanese population","volume":"25","author":"Ogihara","year":"2011","journal-title":"Am. J. Rhinol. Allergy"},{"key":"10.1016\/j.jns.2019.116638_bb0065","first-page":"565","article-title":"Usefulness of the odor stick identification test for Japanese patients with olfactory dysfunction","volume":"29","author":"Hashimoto","year":"2004","journal-title":"Chem. Sences"},{"key":"10.1016\/j.jns.2019.116638_bb0070","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/mds.23602","article-title":"Association of olfactory dysfunction and brain. Metabolism in Parkinson\u2019s disease","volume":"26","author":"Baba","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2019.116638_bb0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.parkreldis.2018.05.025","article-title":"High norepinephrinergic orthostatic hypotension in early Parkinson\u2019s disease","volume":"55","author":"Umehara","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2019.116638_bb0080","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s12149-008-0156-x","article-title":"Usefulness of rCBF analysis in diagnosing Parkinson\u2019s disease: supplemental role with MIBG myocardial scintigraphy","volume":"22","author":"Nagamachi","year":"2008","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.jns.2019.116638_bb0085","doi-asserted-by":"crossref","first-page":"64499","DOI":"10.18632\/oncotarget.16469","article-title":"Neutrophil count and percentage: potential independent prognostic indicators for advanced cancer patients in a palliative care setting","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jns.2019.116638_bb0090","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s12094-018-1999-9","article-title":"Pretreatment neutrophil\/lymphocyte, platelet\/lymphocyte, lymphocyte\/monocyte, and neutrophil\/monocyte ratios and outcome in elderly breast cancer patients","volume":"21","author":"Losada","year":"2019","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.jns.2019.116638_bb0095","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10072-014-1976-1","article-title":"The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil\/lymphocyte ratio in Parkinson\u2019s disease","volume":"36","author":"Ak\u0131l","year":"2015","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jns.2019.116638_bb0100","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10072-016-2758-8","article-title":"Comparison of neutrophil-lymphocyte ratio (NLR) in Parkinson\u2019s disease subtypes","volume":"38","author":"Ata\u00e7 U\u00e7ar","year":"2017","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jns.2019.116638_bb0105","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1212\/WNL.0b013e3181d5a4a3","article-title":"Anti-inflammatory drugs and risk of Parkinson\u2019s disease: a meta-analysis","volume":"74","author":"Gagne","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.116638_bb0110","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1212\/WNL.0b013e318281cc99","article-title":"CARPA Study Group, Prognostic factors of motor impairment, disability, and quality of life in newly diagnosed PD","volume":"80","author":"Velseboer","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.116638_bb0115","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1212\/WNL.0000000000002768","article-title":"Postural instability and gait are associated with severity and prognosis of Parkinson\u2019s disease","volume":"86","author":"Van der Heeden","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.116638_bb0120","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/jnnp.2005.081711","article-title":"Motor subtype and cognitive decline in Parkinson\u2019s disease, Parkinson\u2019s disease with dementia, and dementia with Lewy bodies","volume":"77","author":"Burn","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.116638_bb0125","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1212\/01.WNL.0000137886.74175.5A","article-title":"Homocysteine and levodopa: should Parkinson disease patients receive preventative therapy?","volume":"63","author":"Postuma","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.116638_bb0130","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/hr.2016.30","article-title":"Increased neutrophil to lymphocyte ratio in persons suffering from hypertension with hyperhomocysteinemia","volume":"39","author":"Gang","year":"2016","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.jns.2019.116638_bb0135","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/WNL.0000000000001999","article-title":"Is normosmic Parkinson disease a unique clinical phenotype?","volume":"85","author":"Lee","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.116638_bb0140","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jamaneurol.2015.4265","volume":"73","author":"Wills","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2019.116638_bb0145","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1212\/WNL.0b013e3181ca014c","article-title":"Association of anosmia with autonomic failure in Parkinson disease","volume":"74","author":"Goldstein","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.116638_bb0150","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/ane.12633","article-title":"Body weight and dysautomomia in early Parkinson\u2019s disease","volume":"135","author":"Umehara","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2019.116638_bb0155","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/jnnp-2017-317134","article-title":"Peripheral inflammation in prodromal Alzhemier\u2019s and Lewy body dementias","volume":"89","author":"King","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19324037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19324037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:50:38Z","timestamp":1758383438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X19324037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":31,"alternative-id":["S0022510X19324037"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2019.116638","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential leukocyte count is associated with clinical phenotype in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2019.116638","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116638"}}